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The CDC estimates that with more than 40,000 new infections annually, more than 1.2 million people in the United 
States are living with HIV—and 24% to 27% 
may not be aware of their infection status.1 
Studies have shown that HIV is often diagnosed 
late in the disease process, when the individual 
has already developed AIDS, which typical-
ly occurs 8 to 11 years after HIV infection.2 
Research also points to missed opportunities 
to offer HIV testing and diagnose the infection 
before AIDS develops, which would enable the 
newly diagnosed individuals to employ precau-
tions to protect their partners from becoming 
infected.3,4 Almost half of HIV transmissions 
studied by Brenner et al were attributed to 
transmission by newly infected persons.5 
In response to these issues, the CDC put forth 
revised recommendations for HIV testing that 
encourage screening for patients in all health-
care settings after the person is notifi ed that test-
ing will be performed, unless he or she declines 
(opt-out screening).4 Primary-care providers 
need a better understanding of trends in HIV 
infection and what to do when an HIV test is 
positive. In a recent survey of 1,165 primary-
care providers, 54% of the respondents reported 
treating HIV-positive individuals, with 43% 
indicating an “increased” or a “dramatically 
increased” caseload over the past year.6 
HIV viral dynamics 
HIV is classifi ed as a retrovirus that is com-
pletely dependent on CD4 T cells for copying 
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and transmission of 
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converted to DNA.
HIV: Make the diagnosis 
and take the next step
With the CDC urging screening for all willing patients, providers will be 
testing and managing a growing number of HIV-positive individuals.
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and surviving. The virus enters the CD4 T cell by bind-
ing onto receptors and fusing with the lipid outer layer. 
The virus then converts its ribonucleic acid (RNA) to 
deoxyribonucleic acid (DNA) through the enzyme reverse 
transcriptase. The enzyme integrase helps the virus to 
become part of the human DNA in the cell’s nucleus. 
During transcription and translation, enzymes assist the 
HIV genes by converting them into messenger RNA, which 
then leaves the nucleus with the HIV codes within. The 
enzyme protease makes smaller pieces of the long strands 
of protein; these pieces become mature viral cores. The 
new virions bud from the CD4 T cell and go on to infect 
other cells and repeat the process. HIV can replicate itself 
billions of times each day. 
Signs and symptoms of HIV infection 
Acute retroviral syndrome (ARS) occurs early in the new 
infection. Approximately 50%-70 % of HIV-positive persons 
will experience an infl uenzalike illness that may consist of 
one symptom or a constellation of symptoms including fever, 
rash, pharyngitis, lymphadenopathy, and myalgias. Because 
these symptoms are nonspecifi c and frequently resolve on 
their own, without a high index of suspicion clinicians may 
not consider HIV infection in the differential diagnosis. 
An exposed individual usually becomes symptomatic two 
to four weeks after transmission and will have a markedly 
high HIV viral load (amount of virus in the serum).
The asymptomatic period of HIV infection can last 
from a few months to up to 15 years. This varies from 
person to person and is usually associated with the level of 
HIV viral load—typically, those with higher viral loads 
deteriorate faster than those with lower loads. During this 
time, the CD4 T cells usually decline at an average rate of 
approximately 50 cells/µL/year. The CDC defi nes AIDS as 
persons with both documented HIV infection and CD4 T 
cells <200/mm3 whether other AIDS-defi ning conditions 
are present or not, or the presence of an AIDS-defi ning 
condition (Table 1). 
Many patients will be asymptomatic during the clinical 
latency period, but various nonspecifi c fi ndings on physi-
cal examination and in lab tests are associated with HIV. 
Generalized nontender lymphadenopathy involving the 
cervical, occipital, and/or axillary nodal chains is very 
common and can persist beyond primary infection. The 
presence of unexplained fevers, weight loss, night sweats, 
dementia, and neuropathy help rule in HIV infection. Skin 
lesions may be suggestive of HIV infection. Seborreahic der-
matitis, psoriasis, molluscum contagiousum, and extensive 
TABLE 1. CDC list of AIDS-defi ning conditions
Bacterial infections, multiple or recurrent* 
Candidiasis of bronchi, trachea, or lungs 
Candidiasis of esophagus† 
Cervical cancer, invasive§ 
Coccidioidomycosis, disseminated or extrapulmonary 
Cryptococcosis, extrapulmonary 
Cryptosporidiosis, chronic intestinal (more than one month’s duration) 
Cytomegalovirus disease (other than liver, spleen, or nodes), onset at 
age >1 month 
Cytomegalovirus retinitis (with loss of vision)† 
Encephalopathy, HIV-related 
Herpes simplex: chronic ulcers more than one month’s duration) or 
bronchitis, pneumonitis, or esophagitis (onset at age >1 month) 
Histoplasmosis, disseminated or extrapulmonary 
Isosporiasis, chronic intestinal (more than one month’s duration) 
Kaposi sarcoma† 
Lymphoid interstitial pneumonia or pulmonary lymphoid 
hyperplasia complex*† 
Lymphoma, Burkitt (or equivalent term) 
Lymphoma, immunoblastic (or equivalent term) 
Lymphoma, primary, of brain 
Mycobacterium avium complex or Mycobacterium kansasii, disseminated 
or extrapulmonary† 
Mycobacterium tuberculosis of any site, pulmonary,†§ disseminated,† or 
extrapulmonary† 
Mycobacterium, other species or unidentifi ed species, disseminated† 
or extrapulmonary† 
Pneumocystis jirovecii pneumonia† 
Pneumonia, recurrent†§ 
Progressive multifocal leukoencephalopathy 
Salmonella septicemia, recurrent 
Toxoplasmosis of brain, onset at age >1 month† 
Wasting syndrome attributed to HIV
* Only among children aged <13 years.  
† Condition that might be diagnosed presumptively. 
§ Only among adults and adolescents aged >13 years. 
Source: Schneider E, Whitmore S, Glynn MK, et al. Revised surveillance case defi nitions 
for HIV infection among adults, adolescents, and children aged <18 months and for HIV 
infection and AIDS among children aged 18 months to <13 years — United States, 2008. 
MMWR Recomm Rep. 2008;57(RR-10):1-12. Available at www.cdc.gov/mmwr/preview
/mmwrhtml/rr5710a1.htm; accessed June 10, 2010.
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People with HIV are living longer and developing 
chronic diseases common to aging such as 
diabetes, cardiovascular disease, and osteoporosis.
.pdf [accessed June 10, 2010] for current guidelines on the use 
of antiretroviral agents in persons with HIV infection.)
Despite its benefi ts, HAART may be a lifelong regimen, 
and has short- and long-term implications that need to be 
considered when initiating therapy. Viruses can become 
resistant to certain antiretrovirals, and resistant virus can 
be transmitted to others in the same ways wild-type virus 
is transmitted (via blood or breast milk, sexually, or peri-
natally). Genotype resistance testing can be done to try to 
identify mutations that confer drug resistance. 
Additionally, many of the HIV medications interact with 
commonly prescribed drugs. One study has estimated 
that HIV-positive individuals have an average life span 21 
years shorter than their HIV-negative counterparts.7 This 
is why after being diagnosed as HIV-positive, the patient 
should undergo a full history and physical examination to 
detect additional health issues that may be exacerbated by 
HIV and therapy. Initial labs must include an HIV viral 
load and CD4 T cell count, which will inform progno-
sis and determine the degree of urgency for initiating 
prophylaxis for opportunistic infections and HAART. 
Opportunistic infection can manifest at any CD4 T cell level; 
however, risk increases once CD4 T cell count drops below 
200 cells/mm3. Accepted thresholds of 200, 100, and 50 
cells/mm3 have been established, signifying risk of Pneumocystis 
jiroveci, Mycobacterium avium, and Toxoplasma gondii complex 
condyloma are all diagnoses associated with HIV infec-
tion. Oral candidiasis (thrush) and oral hairy leukoplakia 
may be seen when CD4 T cells fall to less than 500/mm3. 
Recurrent or severe herpetic lesions and chronic vaginal 
candidiasis should prompt consideration of HIV testing. 
Unexplained anemia, neutropenia, leukopenia, and an 
elevated protein level are all commonly seen laboratory 
abnormalities caused by HIV infection. 
Diagnosis of HIV infection 
During ARS, the viral load is very high—often >100,000 
copies/mL. The standard test to detect ARS is the reverse 
transcriptase-polymerase chain reaction (RT-PCR). False-
positive HIV viral loads do occur. If ARS is suspected, viral 
loads of <10,000 copies/mL should be repeated as this result 
may be a false positive or can indicate that the patient has had 
chronic HIV. Practitioners should note that the standard test 
for diagnosing HIV is the enzyme-linked immunosorbent 
assay (ELISA), which is confi rmed with a Western blot. 
During ARS, the ELISA will likely be negative; the Western 
blot may be negative or indeterminate. These fi ndings are 
consistent with the time needed for seroconversion—the 
development of antibodies to HIV. Seroconversion can take 
three to six months after infection.
After the diagnosis
Morbidity and mortality from HIV/AIDS has decreased 
signifi cantly and people with HIV are living longer and 
developing chronic diseases common to aging such as dia-
betes, cardiovascular disease, and osteoporosis. This shift is 
attributable to the introduction of highly active antiretroviral 
therapy (HAART). Antiretroviral agents can be classifi ed 
into six basic categories: 
nucleoside reverse transcriptase inhibitors• 
non-nucleoside reverse transcriptase inhibitors• 
protease inhibitors• 
entry inhibitors• 
fusion inhibitors• 
integrase inhibitors.• 
Some of these drugs are manufactured in combination 
forms. Current recommendations suggest that if a patient 
is ready to start therapy, a three-drug regimen is preferable. 
(See aidsinfo.nih.gov/contentfi les/AdultandAdolescentGL
TABLE 2. Recommended initial laboratory workup
CD4 panel
HIV viral load 
HIV genotype (also consider tropism testing for CCR5, CX)
Complete blood count
Renal function tests
Liver enzymes
Hepatitis serologies (hepatitis A, B, C)
Toxoplasmosis antibody
Cytomegalovirus antibody
Urinalysis
Rapid plasma reagin/Veneral Disease Research Laboratory 
Gonorrhea/Chlamydia 
Fasting lipid profi le
Herpes simplex virus
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infection fi rst came to the forefront when medication 
options were limited. ■
Dr. Stewart is assistant professor, Sacred Heart University Nursing 
Program, in Fairfi eld, Conn. Dr. Weinberg is a family nurse practitio-
ner specializing in HIV at Stamford Hospital in Stamford, Conn.
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infections, respectively; primary prophylaxis is recommend 
at these points.8 Standard recommended initial laboratory 
workup is summarized in Table 2. Recommendations for 
prophylaxis of opportunistic infections can be found on the 
CDC Web site (www.cdc.gov/mmwr/preview/mmwrhtml
/rr5804a1.htm; accessed June 10, 2010).
Referral to an HIV specialist is preferred, although initial 
laboratory workup can be done prior to the consultation to 
foster a more thorough discussion of the patient’s options. 
Research has shown that quality of care for HIV patients is 
improved when the provider is an HIV specialist;9 often the 
specialists are nurse practitioners or physician assistants. 
In most cases, CD4 T cell levels and HIV viral load are 
checked every three months, with monitoring of CBC, 
metabolic panels, and lipid profi les every three to six months. 
Yearly tuberculosis testing (PPD), RPR testing, ophthalmo-
logic and dental exams, gynecology exams (possibly necessary 
every six months if CD4 T cell count is low and/or dysplasia 
is present) should be done. Routine health maintenance 
screenings as per the general population include mam-
mography, prostate-specifi c antigen screening, colonoscopy, 
electrocardiograms, and stress testing. 
Conclusion
Compassionate, knowledgeable health-care providers can 
improve the likelihood that persons newly diagnosed with 
HIV infection will obtain the appropriate information to 
make good choices, prevent spread of the disease, and improve 
their own morbidity and mortality risks. 
In summary, primary-care practitioners should:
Verify presence of HIV infection with Western blot.• 
Obtain baseline labs and perform a comprehensive physi-• 
cal assessment.
Consult with an HIV specialist for plan of care.• 
Reassure patient that with 100 % adherence to therapy, • 
life expectancy is much longer than it was when HIV 
AT A GLANCE
● In one survey, 54% of primary-care providers reported 
treating HIV-positive individuals.
● The asymptomatic period of HIV infection can last from a 
few months to up to 15 years.
● Decreased morbidity and mortality from HIV/AIDS is 
attributable to higly active antiretroviral therapy.
● After diagnosis, HIV-positive patients should undergo a full 
history and physical examination.
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